Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Arthroscopic evaluation of potential structure-modifying drug in osteoarthritis of the knee. A multicenter, randomized, double-blind comparison of tenidap sodium vs piroxicam.
Ayral X, Mackillop N, Genant HK, Kirkpatrick J, Beaulieu A, Pippingskiöld P, Will RK, Alava S, Dougados M. Ayral X, et al. Among authors: will rk. Osteoarthritis Cartilage. 2003 Mar;11(3):198-207. doi: 10.1016/s1063-4584(02)00353-9. Osteoarthritis Cartilage. 2003. PMID: 12623291 Free article. Clinical Trial.
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
Gutteridge DH, Holzherr ML, Retallack RW, Price RI, Will RK, Dhaliwal SS, Faulkner DL, Stewart GO, Stuckey BG, Prince RL, Criddle RA, Drury PJ, Tran L, Bhagat CI, Kent GN, Jamrozik K. Gutteridge DH, et al. Among authors: will rk. Calcif Tissue Int. 2003 Jul;73(1):33-43. doi: 10.1007/s00223-002-2023-4. Calcif Tissue Int. 2003. PMID: 14506952 Clinical Trial.
Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers.
Holzherr ML, Retallack RW, Gutteridge DH, Price RI, Faulkner DL, Wilson SG, Will RK, Stewart GO, Stuckey BG, Prince RL, Criddle RA, Kent GN, Bhagat CI, Dhaliwal SS, Jamrozik K. Holzherr ML, et al. Among authors: will rk. Osteoporos Int. 2000;11(1):43-51. doi: 10.1007/s001980050005. Osteoporos Int. 2000. PMID: 10663358 Clinical Trial.
Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, Ward L. Randall AG, et al. Among authors: will rk. J Bone Miner Res. 1996 Aug;11(8):1176-84. doi: 10.1002/jbmr.5650110817. J Bone Miner Res. 1996. PMID: 8854254 Free article. Clinical Trial.
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.
Gutteridge DH, Ward LC, Stewart GO, Retallack RW, Will RK, Prince RL, Criddle A, Bhagat CI, Stuckey BG, Price RI, Kent GN, Faulkner DL, Geelhoed E, Gan SK, Vasikaran S. Gutteridge DH, et al. Among authors: will rk. J Bone Miner Res. 1999 Oct;14 Suppl 2:79-84. doi: 10.1002/jbmr.5650140216. J Bone Miner Res. 1999. PMID: 10510219 Free article. Clinical Trial.
28 results